David Peyser

David Peyser has had a varied work experience. David began their career as an Investment Banking Analyst at Guggenheim Partners in 2017. David then moved on to become an Associate at Telsey Advisory Group in 2018, and also took on the role of Project Associate at the New York Genome Center in the same year. In 2019, they became an Investment Analyst at BTG Pactual, and they are currently the Director of Finance at C2i Genomics, a position they have held since 2022.

David Peyser obtained a Bachelor's Degree in American History from Columbia University between 2014 and 2017, graduating with Phi Beta Kappa and Magna Cum Laude honors.